Dr Reddys Laboratories Share Price Today - Live Blog for October 13, 2025

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.19% gain, with the share price now at ₹1,263.50. Notably, the stock's PE ratio stands at 18.3800, and its Return on Equity (ROE) is 16.8559%.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.04% increase. Presently, it is actively trading at ₹1,263.70.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.24% boost, with the current market value at ₹1,262.05 per share. This surge has not gone unnoticed by investors.

Dr Reddys Laboratories Ltd stock stayed at its current value, with no movement, and is trading at ₹1,259.00. The stock has a PE ratio of 18.3800, an ROE of 16.8559%, and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.24%, and as of now, it's trading at ₹1,259.00 per share. This upward trajectory is attracting keen interest from investors.

Demonstrating a commendable 0.14% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,256.00. In terms of valuation, the stock maintains a PE ratio of 18.3800, while the industry PE ratio stands at 35.0675.

The stock of Dr Reddys Laboratories Ltd is facing a -0.02% decline and is currently trading at ₹1,254.20 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.04%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,254.00 per share.

Dr Reddys Laboratories Ltd's share price remained the same, currently trading at ₹1,253.00. This unchanging trend might prompt investors to reevaluate their investment thesis and consider factors influencing the stock's stability.

Dr Reddys Laboratories Ltd witnessed a notable 0.12% surge in its share price and is presently trading at ₹1,253.05, captivating the attention of market participants.

After a significant 0.12% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,252.45 in the current market. This upward movement is attracting attention from both retail and institutional investors.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.26% drop, and it's now trading at ₹1,251.00 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

With a -0.26% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,251.00. The stock is currently trading at a PE of 18.3800, while the industry PE is 35.0675, prompting investors to assess its value proposition.

The stock of Dr Reddys Laboratories Ltd suffered a -0.26% decline, and it currently trades at ₹1,251.00 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd observed a remarkable 0.23% surge in its share price and is presently trading at ₹1,254.30. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd's share price has dropped by -0.01%, a development that warrants careful analysis. Presently trading at ₹1,253.30, investors are assessing whether this presents an opportunity or a risk.

After a notable 0.10% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,253.55. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd share price surged by 0.11%. With its current market price standing at ₹1,251.95 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.20% uptick in its share price. As a result, it's now actively trading at ₹1,250.80 per share, making it an attractive option for investors.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.06%, signalling a challenging period. Currently trading at ₹1,248.80, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd's share price has fallen by -0.12%, a situation worth noting. At present, the stock is trading at ₹1,251.00. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.3800, while the industry PE ratio is 35.0675.

Dr Reddys Laboratories Ltd's share price has dropped by -0.12%, a development that warrants careful analysis. Presently trading at ₹1,251.00, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd experienced a -0.12% downturn in its share price, and it's currently trading at ₹1,251.00. This situation is generating interest among value investors who are evaluating the stock's potential.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.05% gain, with the share price now at ₹1,251.25. Notably, the stock's PE ratio stands at 18.3800, and its Return on Equity (ROE) is 16.8559%.

Dr Reddys Laboratories Ltd shares saw a -0.29% decrease, reaching a current market price of ₹1,249.30. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.3800, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

With a remarkable 0.20% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,252.95. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.3800, while the industry's PE ratio is 35.0675.

Dr Reddys Laboratories Ltd stock price decreased by -0.23%, with the current market value at ₹1,252.05 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd shares experienced a -0.33% reduction, with the current market price at ₹1,254.00. Investors are carefully considering their positions and seeking insights into the stock's future performance.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 1.70% increase and currently trading at ₹1,260.10 per share. Investors are taking notice of this upward momentum.